Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001047469-21-000930
Filing Date
2021-04-13
Accepted
2021-04-12 17:45:15
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B3 a2243197z424b3.htm 424B3 2977486
2 G967154.JPG g967154.jpg GRAPHIC 10704
3 G520691.JPG g520691.jpg GRAPHIC 8819
4 G814640.JPG g814640.jpg GRAPHIC 3392
5 G456188.JPG g456188.jpg GRAPHIC 3107
6 G167339.JPG g167339.jpg GRAPHIC 9771
7 G150974.JPG g150974.jpg GRAPHIC 4016
  Complete submission text file 0001047469-21-000930.txt   3034256
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-253315 | Film No.: 21821541
SIC: 2834 Pharmaceutical Preparations